Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7535-7539

  Tsao, Yeou Ping ^a   Li, Long Yuan ^a   Tsai, Tzung Chieh ^a   Chen, Show Li ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; MUTANT PROTEIN; PROTEIN P21; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE C JUN; PAPILLOMA VIRUS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS CELL TRANSFORMATION; VIRUS STRAIN; WART VIRUS;

EID: 0029839485     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7535-7539.1996     Document Type: Article

References (32)

1. Bouvard, V., G. Matlashewski, Z. M. Gu, A. Storey, and L. Banks. 1994. The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. Virology 203:73-80.
2. Chen, S. L., C. P. Han, and Y. P. Tsao. 1993. Construction of site-specific mutants of E5a protein of HPV-11 by polymerase chain reaction and a single mutant primer. J. Virol. Methods 42:89-94.
3. Chen, S. L., C. H. Huang, T. C. Tsai, K. Y. Lu, and Y. P. Tsao. 1996. The regulation mechanism of c-jun and junB by human papillomavirus type 16 E5 oncoprotein. Arch. Virol. 141:791-800.
4. Chen, S. L., and P. Mounts. 1990. Transforming activity of E5a protein of human papillomavirus type 6 in NIH 3T3 cells and C127 cells. J. Virol. 64:3226-3233.
5. Chen, S. L., T. C. Tsai, C. P. Han, and Y. P. Tsao. 1996. Mutational analysis of human papillomavirus type 11 E5a oncoprotein. J. Virol. 70:3502-3508.
6. Chen, S. L., L. T. Tsao, and Y. P. Tsao. 1994. Antiscnsc oligodeoxynucleotides to c-jun inhibits proliferation of transformed NIH 3T3 cells induced by E5a of HPV-11. Cancer Lett. 85:119-123.
7. Chen, S. L., Y. P. Tsao, C. M. Yang, Y. K. Lin, C. H. Huang, and S. W. Kuo. 1995. Differential induction and regulation of c-jun, junB, junD and c-fos by human papillomavirus type 11 E5a oncoprotein. J. Gen. Virol. 76:2653-2659.
8. Conrad, M., V. J. Bubb, and R. Schlegel. 1993. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J. Virol. 67:6170-6178.
9. Conrad, M., D. Goldstein, T. Andresson, and R. Schlegel. 1994 The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors. Virology 200:796-800.
10. Defeo-Jones, D., G. A. Vuocolo, K. M. Haskell, M. G. Hanobik, D. M. Kiefer, E. M. McAvoy, M. Ivey-Hoyle, J. L. Brandsma, A. Oliff, and R. E. Jones. 1993. Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts. J. Virol. 67:716-725.
11. El-Deiry, W. S., J. W. Harper, P. M. O'Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, and Y. Wang. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis Cancer Res. 54:1169-1174.
12. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
13. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dcpendent kinases. Cell 75:805-816.
14. Hawley-Nelson, P., K. H. Vousden, N. L. Hubbert, D. R. Lowy, and J. Schiller. 1989. HPV 16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8:3905-3910.
15. Howley, P. M. 1991. Role of the human papillomaviruses in human cancer. Cancer Res. 51(Suppl):5019s-5022s.
16. Hwang, E. S., T. Nottoli, and D. DiMaio. 1995. The HPV-16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology 211:227-233.
17. Jewers, R. J., P. Hildebrandt, J. W. Ludlow, B. Kell, and D. J. McCance. 1992. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes. J. Virol. 66:1329-1335.
18. Jiang, H., J. Lin, S. Zao-Zhong, F. R. Collart, E. Huberman, and P. B. Fisher. 1994. Induction of differentiation in human promyelocytic HL60 leukemia cells activates p21, WAF1/CIP1, expression in the abscence of p53. Oncogene 9:3397-3406.
19. Leechanachai, P., L. Banks, F. Moreau, and G. Matlashewski. 1992. The ES gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene 7:19-25.
20. Leptak, C., Y. Ramon, S. Cajal, R. Kulke, B. H. Horwitz, D. J. Riese II, G. P. Dotto, and D. DiMaio. 1991. Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16. J. Virol. 65:7078-7083.
21. Noda, A., Y. Ning, S. F. Venable, S. O. Pereira, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
22. Pim, D., M. Collins, and L. Banks. 1992. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 7:27-32.
23. Ryder, K., and D. Nathans. 1988. Induction of protooncogene c-jun by serum growth-factors. Proc. Natl. Acad. Sci. USA 85:8464-8467.
24. Sherr, C. 1994. GI phase progression: cycling on cell. Cell 79:551-555.
25. Straight, S. M., P. M. Hinkle, R. J. Jewers, and D. J. McCance. 1993. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 67:4521-4532.
26. Tsao, Y. P., T. Y. Chu, T. M. Chen, Y. F. Yang, and S. L. Chen. 1994. Effects of E5a and E7 of human papillomavirus type 11 on immortalized human epidermal keratinocytes and NIH 3T3 cells. Arch. Virol. 138:177-185.
27. Tsao, Y. P., C. H. Huang, Y. K. Lin, and S. L. Chen. 1995. Protein kinase C-and ras-dependent activation of c-jun gene by human papillomavirus type 11 E5a oncoprotein. Cancer Lett. 95:201-205.
28. Tsao, Y. P., S. W. Kuo, S. F. Li, J. C. Liu, S. Z. Lin, K. Y. Chen, and S. L. Chen. 1995. Differential regulation of cyclin A, cyclin B, and p21 concentrations in a growth-restricted human fibroblast cell line. Biochem. J. 312:693-698.
29. Tsao, Y. P., S. W. Kuo, S. F. Li, T. C. Tsai, L. Y. Li, and S. L. Chen. 1995. Human papillomavirus 11 E5a delays the growth restriction induced by temperature shift in temperature sensitive simian virus 40 T antigen immortalized keratinocytes. Biochem. Biophys. Res. Commun. 217:712-720.
30. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature (London) 366: 701-704.
31. Xiong, Y., H. Zhang, and D. Beach. 1993. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7:1572-1583.
32. zur Hausen, H. 1991. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13.